SharadaASarnaikMD
Pediatric Hematology & Oncology • Detroit, MIProfessor, Pediatrics, Wayne State University School of Medicine
Dr. Sarnaik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Childrens Hospital MI Hematologyoncology
3901 Beaubien 2ND floor Carlaposs Building
Detroit, MI 48201Phone+1 313-745-5515Fax+1 313-745-5420
Education & Training
Children's Hospital of MichiganResidency, Pediatrics, 1974 - 1975
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1973 - 1974- Children's Hospital of MichiganResidency, Pediatrics, 1971 - 1973
- Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 1970 - 1971
Grant Medical CollegeClass of 1969- Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology
Certifications & Licensure
MI State Medical License 1973 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia Start of enrollment: 2000 Aug 01
- A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Start of enrollment: 2013 Apr 01
- Screening Patients With Sickle Cell Disease for Kidney Damage Start of enrollment: 2009 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsLong-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.Darla K. Liles, Nirmish Shah, Brigid Scullin, Victor R. Gordeuk, Wally R. Smith
British Journal of Haematology. 2021-10-05 - 23 citationsEffect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.James F. Casella, Bruce A. Barton, Julie Kanter, L. Vandy Black, Suvankar Majumdar
JAMA. 2021-04-20 - 30 citationsProgression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.Omar Niss, Adam Lane, Monika Asnani, Marianne E.M. Yee, Ashok Raj
Blood Advances. 2020-04-14
Journal Articles
- A Phase 3 Trial of L-glutamine in Sickle Cell DiseaseRita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
